Efficacy News and Research

RSS
Orexigen's Empatic Phase 2b results demonstrate weight loss

Orexigen's Empatic Phase 2b results demonstrate weight loss

HRA Pharma launches its new generation emergency contraceptive in Europe

HRA Pharma launches its new generation emergency contraceptive in Europe

Catalyst Pharmaceutical Partners to continue development of CPP-109 drug

Catalyst Pharmaceutical Partners to continue development of CPP-109 drug

Advaxis announces Phase I trial results of its ADXS11-001 therapeutic cancer vaccine

Advaxis announces Phase I trial results of its ADXS11-001 therapeutic cancer vaccine

CVRx commences enrollment in study evaluating the Rheos System to treat heart failure

CVRx commences enrollment in study evaluating the Rheos System to treat heart failure

Fovea Pharmaceuticals to sell 100% of its share to Sanofi-Aventis

Fovea Pharmaceuticals to sell 100% of its share to Sanofi-Aventis

Cutting Edge Information hopes to see ill patients have speedier access to potential cures

Cutting Edge Information hopes to see ill patients have speedier access to potential cures

Stem cell therapy aims to prevent permanent damage from heart attacks

Stem cell therapy aims to prevent permanent damage from heart attacks

Covidien receives 510(k) clearance to market Mallinckrodt Taperguard Evac endotracheal tube

Covidien receives 510(k) clearance to market Mallinckrodt Taperguard Evac endotracheal tube

Gamida Cell publishes article evaluating Stemex for leukemia and lymphoma

Gamida Cell publishes article evaluating Stemex for leukemia and lymphoma

METI Nurse Residency Program for reducing health care costs

METI Nurse Residency Program for reducing health care costs

58% of Americans believe that H1N1 flu is a serious health hazard: Survey

58% of Americans believe that H1N1 flu is a serious health hazard: Survey

Antidepressant amitriptyline works just as well as placebo for children with gastrointestinal disorders

Antidepressant amitriptyline works just as well as placebo for children with gastrointestinal disorders

Injectible H1N1 vaccine ships ahead of schedule in U.S.

Injectible H1N1 vaccine ships ahead of schedule in U.S.

Update from BioCryst Pharmaceuticals regarding intravenous peramivir

Update from BioCryst Pharmaceuticals regarding intravenous peramivir

Can-Fite BioPharma commences preparatory work for a Phase III trial with CF101 to treat Psoriasis

Can-Fite BioPharma commences preparatory work for a Phase III trial with CF101 to treat Psoriasis

Emergent BioSolutions receives NIAID funding support for dmPA7909 anthrax vaccine candidate

Emergent BioSolutions receives NIAID funding support for dmPA7909 anthrax vaccine candidate

Phase III clinical trial results demonstrate effectiveness of spinosad suspension

Phase III clinical trial results demonstrate effectiveness of spinosad suspension

Non-human primate study results of Restanza released

Non-human primate study results of Restanza released

Medgenics announces unaudited half-yearly results for the six months ended 30 June 2009

Medgenics announces unaudited half-yearly results for the six months ended 30 June 2009

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.